|
|
|
|
|
HSV-2 rGlycoprotein G |
|
|
|
| Catalog Number |
H2V134-100 100 ug |
|
|
| |
H2V134-1 1 mg |
|
| |
|
|
| |
|
|
|
|
| |
|
|
|
|
|
Lot Number |
B0933095 |
|
Expiration Date |
February 2012 |
|
|
|
Virus Strain
Host Cell
Cell Line Characterization
Purity
Inactivation
Supplied in
Protein Concentration
Fill Volume
ELISA (IgG) Titer
Western Blot Titer
Reference and/or Additional Reading |
|
"G"
Baculovirus (Sf-9)
Mycoplasma negative
Infected cell extract enriched for viral proteins
Greater than 90% by SDS-PAGE
50 mM Tris, 5 mM DTT, 1 mM EDTA, 0.1% Triton X-100 pH 8
1.0 mg/ml
100 µl (H1V134-100) or 1.0 ml (H1V134-1)
>1:64,000
10 µg/cm
J. Virol. Methods (1992), 36:249 |
| |
|
|
|
|
ELISA Results
Antigen is Virusys # H1V016 HSV-1 Infected Cell Extract AND H1V134 HSV Recombinant gG-2 coated at various dilutions in PBS. Primary antibodies are human plasmas previously characterized for HSV-2 IgG serology. See SOP-138 for procedure.
|
|
|
|
SDS-PAGE and Western Blot Results
Antigen is Virusys # H1V134 HSV-2 Recombinant gG at 10 µg/cm. Primary antibody is H2A023-100 HSV gG Monoclonal Antibody. See SOP-128 for procedure.
. |
|
|
| |
|
This product is intended for research and manufacturing uses only. It is not a diagnostic device. It is supplied frozen on dry ice - upon receipt, store at -70°C. Product degradation will result from multiple freeze/thaw cycles. It is suggested that the antigen be stored in use size aliquots and thawed just prior to use. Storage at 2 - 8°C for up to twelve hours is acceptable for unused portions. |
|
|
|
|
|
|
